October 13, 2022

From the Co-Chairs, October 2022

Research results in breast and kidney cancer; recognition of key colleagues; and a sneak peek of the Fall 2022 Group Meeting
October 13, 2022

Charmaine Green on Cultivating a Career in Health Care Administration

Health care administrator Charmaine Green shares her experience supporting cancer clinical trials and discusses how her role has evolved over the years
October 13, 2022

Meet the 2022 Young Investigator Symposium Presenters

Eight early-career investigators will present their work; two will be selected to receive awards of distinction
October 13, 2022

Trial Spotlight: Yishai Ofran on the EA9181 Study for Acute Lymphoblastic Leukemia

This phase 3 study aims to explore whether treatment with a TKI plus blinatumomab may be superior to the usual treatment approach for acute lymphoblastic leukemia
October 13, 2022

Institution Spotlight: Michigan Cancer Research Consortium NCORP

A Standing Main Member of ECOG-ACRIN since 1983
October 13, 2022

Trial Results: ECOG-ACRIN Completes the First Randomized Phase 3 Clinical Trial of Neoadjuvant Immunotherapy in Patients with Kidney Cancer

The phase III PROSPER RCC clinical trial demonstrated that priming the immune system with nivolumab before surgery, then continuing nivolumab, did not improve recurrence-free survival in patients with high-risk renal cell carcinoma
October 13, 2022

Trial Results: ECOG-ACRIN Research Round-Up

Summaries of recently published ECOG-ACRIN research results
October 13, 2022

News in Brief, October 2022

Summaries and links to timely information about research results in medical journals, recognition of research leaders, and more